GlassScriptPhysician profile
Huimin Wu
NPI 1083902506
$2,010.36
in general payments reported to CMS, 2019-2025
18 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $665 · 2021: $119 · 2022: $413 · 2023: $453 · 2024: $112 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $552 · Travel and Lodging: $255 · Education: $6.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $551.64 |
| Travel and Lodging | $255.00 |
| Education | $6.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $569.81 | 2019-2023 | Fasenra, Tezspire, Airsupra |
| Astrazeneca Uk Limited | $196.06 | 2022 | |
| Inogen, INC. | $175.47 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Glaxosmithkline, LLC. | $166.68 | 2019-2025 | Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $141.31 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $119.42 | 2021 | |
| United Therapeutics Corporation | $118.55 | 2023 | Tyvaso |
| Insmed, INC. | $107.92 | 2019 | |
| Viatris Specialty LLC | $104.48 | 2025 | Yupelri |
| Pulmonx Corporation | $87.87 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Genzyme Corporation | $53.13 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.25 | 2019 | |
| Vifor Pharma, INC. | $34.47 | 2019 | |
| Portola Pharmaceuticals, LLC | $33.91 | 2019 | |
| Novartis Pharmaceuticals Corporation | $21.19 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $18.23 | 2019 | |
| Electromed, INC. | $12.61 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Huimin Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.